trapidil has been researched along with Recrudescence in 7 studies
Trapidil: A coronary vasodilator agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A large-scale study was conducted to assess the effect of long-term administration of trapidil on the prognosis of patients with angiographic evidence of coronary artery disease (CAD)." | 9.10 | Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). ( Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Origasa, H; Sumiyoshi, T; Yui, Y, 2003) |
| "A large-scale study was conducted to assess the effect of long-term administration of trapidil on the prognosis of patients with angiographic evidence of coronary artery disease (CAD)." | 5.10 | Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). ( Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Origasa, H; Sumiyoshi, T; Yui, Y, 2003) |
| "Trapidil is an antiplatelet drug with specific platelet-derived growth factor antagonism and antiproliferative effects in the rat and rabbit models after balloon angioplasty." | 2.67 | Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Corona ( Balducelli, M; Cantini, L; Casari, A; Chioin, R; De Servi, S; Fabbri, M; Fontanelli, A; Maresta, A; Monici Preti, PA; Repetto, S, 1994) |
| "Thus trapidil was useful in preventing intimal proliferation after PTCA, especially in patients with more than 30% residual stenosis after PTCA." | 2.67 | Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. ( Inden, M; Konishi, T; Nakano, T; Okamoto, S; Setsuda, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, A | 1 |
| Kodama, K | 1 |
| Yui, Y | 1 |
| Nonogi, H | 1 |
| Sumiyoshi, T | 1 |
| Origasa, H | 1 |
| Hosoda, S | 1 |
| Kawai, C | 1 |
| Maresta, A | 2 |
| Balducelli, M | 2 |
| Cantini, L | 2 |
| Casari, A | 2 |
| Chioin, R | 2 |
| Fabbri, M | 1 |
| Fontanelli, A | 2 |
| Monici Preti, PA | 2 |
| Repetto, S | 2 |
| De Servi, S | 1 |
| Raffaghello, S | 1 |
| von Hodenberg, E | 1 |
| Tost, B | 1 |
| Scheffold, T | 1 |
| Okamoto, S | 1 |
| Inden, M | 1 |
| Setsuda, M | 1 |
| Konishi, T | 1 |
| Nakano, T | 1 |
| Karas, SP | 1 |
| Santoian, EC | 1 |
| Gravanis, MB | 1 |
| Liu, MW | 1 |
| Roubin, GS | 1 |
| Robinson, KA | 1 |
| Black, AJ | 1 |
| Hearn, JA | 1 |
| Siegel, RJ | 1 |
| King, SB | 1 |
1 review available for trapidil and Recrudescence
| Article | Year |
|---|---|
Restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronary Disease; Disease Models, Ani | 1991 |
4 trials available for trapidil and Recrudescence
2 other studies available for trapidil and Recrudescence
| Article | Year |
|---|---|
[New strategies in the treatment of restenosis].
Topics: Angioplasty, Balloon, Coronary; Angioplasty, Balloon, Laser-Assisted; Anticholesteremic Agents; Athe | 2000 |
Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Cell Division; Female; Iliac Artery; Male; Muscle, | 1990 |